"Designing Growth Strategies is in our DNA"
The global gynecomastia procedures market size was valued at USD 481.8 million in 2025. The market is projected to grow from USD 507.8 million in 2026 to USD 812.3 million by 2034, exhibiting a CAGR of 6.0% during the forecast period.
Gynecomastia procedures are treatments used to reduce enlarged male breast tissue and create a flatter chest shape. The market majorly includes surgical correction of excess chest fat, gland tissue, or both, usually through liposuction, direct gland removal, or a combination of the two. The market growth is prominently driven by increasing number of men who are seeking treatment for body confidence, comfort, and mental well-being. In addition, rising awareness around male aesthetic procedures is also expected to have a positive impact on the market growth. In addition, the market is also accelerated by rising prevalence of obesity, hormonal imbalance, medication-related breast enlargement, and broader social acceptance of cosmetic surgery for men.
Furthermore, many key industry players, such as The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, and Apollo Cosmetic Clinics operating in the market, are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.
Rising Focus on Adoption of Liposuction-Led Treatment Approaches is a Key Market Trend
A clear trend in this market is the growing use of liposuction-led treatment, especially in cases where chest enlargement includes a large fat component. Moreover, clinics increasingly present liposuction as the starting point, as it allows contouring with smaller scars and can be combined with gland excision when needed. This fits well with the broader move toward minimally invasive aesthetic surgery. Device and training activity also supports this trend.
Download Free sample to learn more about this report.
Rising Prevalence of Obesity and Lifestyle-Related Hormonal Imbalance to Accelerate Market Growth
Rising prevalence of obesity and lifestyle-related hormonal imbalance is prominently driving the global gynecomastia procedures market growth. Increased body fat levels can lead to higher estrogen activity in men, which contributes to the development of enlarged breast tissue. In addition, modern lifestyle factors such as poor diet, lack of physical activity, alcohol consumption, and use of certain medications are also contributing to this condition. As awareness improves, more men are recognizing gynecomastia as a treatable issue rather than ignoring it. This is leading to higher consultation rates and eventually more procedures, especially among urban populations where lifestyle-related health concerns are more common.
High Out-Of-Pocket Treatment Cost to Deter Market Growth
Gynecomastia procedures are often treated as elective or cosmetic, which means many patients must pay largely out of pocket. That makes some men delay treatment even when the condition affects comfort or confidence. In addition to surgeon fees, patients also consider anesthesia, facility costs, recovery time, and time away from work. In addition, cost becomes an even bigger barrier in markets where insurance support is limited or where premium body-contouring clinics dominate the service landscape.
Expansion of Minimally Invasive Body Contouring Services to Offer Lucrative Market Growth Opportunities
A strong market opportunity is the expansion of minimally invasive body contouring services that can be adapted for male chest reduction cases. Many providers are promoting shorter downtime, awake procedures, and faster recovery, which can make treatment more acceptable to working-age patients. For instance, AirSculpt continued opening new body contouring centers in 2024 across Columbus, Deerfield, Birmingham, and White Plains, while promoting minimally invasive fat removal and skin tightening services.
Stigma and Delayed Decision-Making to Pose a Critical Challenge to Market Growth
One important challenge is that many men still delay treatment due to embarrassment, stigma, or the belief that the condition will resolve on its own. In addition, unlike many other aesthetic procedures, gynecomastia treatment often involves a long decision cycle. Moreover, men may spend years hiding the condition before consulting a surgeon. This slows the market even when demand exists. Another challenge is that the condition is not always caused by fat alone, so patients need proper diagnosis and realistic counseling.
Adoption of Liposuction Procedures for Removal of Fatty Muscle to Boost Liposuction Procedures Segment Growth
Based on the procedure type, the market is divided into liposuction procedures, excision procedures, and others.
The liposuction procedures segment is anticipated to account for the largest gynecomastia procedures market share. Many gynecomastia cases involve excess fatty tissue along with or instead of gland tissue. Moreover, liposuction is widely preferred as it can improve chest contour through small entry points, support quicker recovery, and be combined with gland removal when needed. It also fits well with current demand for less invasive body-shaping procedures.
The excision procedures segment is anticipated to rise with a CAGR of 5.6% over the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Higher Emphasis on Appearance and Fitness-related Goals of Age Group 18-40 Years to Accelerate Segment Growth
Based on age group, the market is segmented into 18-40 years and above 40 years.
In 2025, the 18-40 years’ segment dominated the global market. The segment growth is attributed to higher emphasis of this age group on appearance, fitness, aesthetics, and social comfort. In addition, growing demand for elective procedures for body countering and its superior results is also projected to have a positive impact on the segment growth.
The above 40 years’ segment is anticipated to rise with a CAGR of 5.7% over the forecast period.
High Demand of Consumables is Likely to Boost Segment Growth
Based on indication, the market is segmented into physiological gynecomastia, drug-induced gynecomastia, and others.
In 2025, the physiological gynecomastia segment dominated the global market. It is the most common everyday presentation witnessed in practice. These are cases linked to natural hormone-related changes, age, weight gain, puberty history, or common metabolic factors, rather than rare tumors or highly unusual causes. Since most men presenting for surgery do so for long-standing chest fullness that developed gradually, this indication naturally represents the biggest treatment pool. In addition, growth in obesity and rising awareness about men’s body image also support demand in this segment.
The drug-induced gynecomastia segment is anticipated to rise with a CAGR of 5.6% over the forecast period.
Higher Production of Medical Device Companies to Accelerate Segment Growth
Based on service provider, the market is segmented into hospitals & ASCs, specialty cosmetic surgery clinics, and others.
In 2025, specialty cosmetic surgery clinics held the highest market share. Gynecomastia treatment is usually planned, elective, and appearance-focused. These clinics are built around body contouring consultations, before-and-after marketing, surgeon specialization, and high procedure throughput. Moreover, patients often prefer them as they offer targeted expertise in liposuction, male chest contouring, and aesthetic recovery management. Provider expansion also indicates where the market is concentrated. Furthermore, the segment is set to hold a 54.9% share in 2026.
In addition, hospitals & ASCs segment is projected to grow at a CAGR of 6.0% during the forecast period.
By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.
North America Gynecomastia Procedures Market Size, 2025 (USD Million)
To get more information on the regional analysis of this market, Download Free sample
North America held the dominant share in 2024, valued at USD 164.4 million, and also maintained the leading share in 2025, with USD 172.6 million. The market in North America is expected to increase due to higher emphasis on male aesthetics, rising prevalence of obesity, and growing number of product launches.
Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 155.9 million in 2026, accounting for roughly 30.7% of global gynecomastia procedures sales.
Europe is projected to record a growth rate of 5.5% in the coming years, and reach a valuation of USD 154.2 million by 2026. The region is estimated to witness considerable market growth due to strong developments in minimally invasive surgical procedures, and increasing disposable incomes.
The U.K. market in 2026 is estimated at around USD 25.9 million, representing roughly 5.1% of global revenues.
Germany’s market is projected to reach approximately USD 35.6 million in 2026, equivalent to around 7.0% of global sales.
Asia Pacific is estimated to reach USD 135.8 million in 2026 and secure the position of the third-largest region in the market.
The Japanese market in 2026 is estimated at around USD 23.9 million, accounting for roughly 4.7% of global revenues.
China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 45.5 million, representing roughly 9.0% of global sales.
The Indian market in 2026 is estimated at around USD 30.5 million, accounting for roughly 6.0% of global revenues.
The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 22.1 million in 2026. In the Middle East & Africa, the GCC is set to reach a value of USD 5.4 million in 2026.
The South Africa’s market is projected to reach around USD 2.2 million in 2026, representing roughly 0.43% of global revenues.
Increasing Number of Product Launches and Substantial Number of Collaborations by Key Players to Boost Market Progress
The global gynecomastia procedures market holds a semi-consolidated market structure, constituting prominent players such as The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, and Apollo Cosmetic Clinics. The significant global market share of these companies is due to numerous strategic activities, including distribution collaborations and implementation of new programs.
Other notable players in the global market, include Fortis Healthcare, VLCC Health Care Ltd., Kaya Limited, and Bangkok Hospital Group. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.
The global gynecomastia procedures market analysis includes a comprehensive study of the market size and forecast for all the market segments included in the report. It includes details on the market dynamics and trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers, and acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a depth competitive landscape with information on the market share and profiles of key operating players.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 6.0% from 2026-2034 |
| Unit | Value (USD Million) |
| Segmentation | By Procedure Type, Age Group, Indication, Service Provider, and Region |
| By Procedure Type |
|
| By Age Group |
|
| By Indication |
|
| By Service Provider |
|
| By Region |
|
According to Fortune Business Insights, the global market value stood at USD 481.8 million in 2025 and is projected to reach USD 812.3 million by 2034.
In 2025, the North Americaβs market value stood at USD 172.6 million.
The market is expected to exhibit a CAGR of 6.0% during the forecast period.
By procedure type, the liposuction procedures segment is expected to lead the market.
Rising emphasis on aesthetic appearance and technological advancements in body countering surgical procedures are the key factors driving the market.
The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, and Apollo Cosmetic Clinics are the major players in the global market.
North America dominated the market in 2025 with the largest share.
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )